PURDUE PHARMA, LP for PURDUE PHARMA LP
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Nov 9, 2012 | $230,000 | Replaced |
| 3rd Quarter - Report (this page) | Nov 9, 2012 | $230,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Alcohol and Drug Abuse ALC
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Copyright/Patent/Trademark CPT
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Health Issues HCR
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.